Journal Club 10/28/22

Monday, October 31, 2022

On Friday, our researchers and physicians discussed a paper that aimed to identify early neurodegenerative pathways in progressive MS.


MS is an autoimmune disease that typically presents as a relapsing-remitting course, followed by a progressive phase. Researchers aimed to understand the molecular pathways of neurodegeneration to facilitate the development of new treatments. Through extensive RNA sequencing of postmortem cortical brain tissue, authors identified specific receptors that could be optimal therapeutic targets in progressive MS. Further research must be done to assess the therapeutic potential of these molecular pathways.

News Archive


Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy


Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.